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Abstract
Background: Polymorphism in genes of regulating enzymes, transporters and receptors of the
neurotransmitters of the central nervous system have been associated with altered behaviour, and
single nucleotide polymorphisms (SNPs) represent the most frequent type of genetic variation. The
serotonin and dopamine signalling systems have a central influence on different behavioural
phenotypes, both of invertebrates and vertebrates, and this study was undertaken in order to
explore genetic variation that may be associated with variation in behaviour.
Results: Single nucleotide polymorphisms in canine genes related to behaviour were identified by
individually sequencing eight dogs (Canis familiaris) of different breeds. Eighteen genes from the
dopamine and the serotonin systems were screened, revealing 34 SNPs distributed in 14 of the 18
selected genes. A total of 24,895 bp coding sequence was sequenced yielding an average frequency
of one SNP per 732 bp (1/732). A total of 11 non-synonymous SNPs (nsSNPs), which may be
involved in alteration of protein function, were detected. Of these 11 nsSNPs, six resulted in a
substitution of amino acid residue with concomitant change in structural parameters.
Conclusion: We have identified a number of coding SNPs in behaviour-related genes, several of
which change the amino acids of the proteins. Some of the canine SNPs exist in codons that are
evolutionary conserved between five compared species, and predictions indicate that they may
have a functional effect on the protein. The reported coding SNP frequency of the studied genes
falls within the range of SNP frequencies reported earlier in the dog and other mammalian species.
Novel SNPs are presented and the results show a significant genetic variation in expressed
sequences in this group of genes. The results can contribute to an improved understanding of the
genetics of behaviour.
Background
Neurotransmitters of the central nervous system (CNS)
indisputably are important for modulation of the dis-
persed behaviour seen in both man and animals. Poly-
morphism in genes of regulating enzymes, transporters
and receptors have been associated with altered behaviour
[1-3]. Single nucleotide polymorphisms (SNPs) represent
the most frequent type of genetic variation in human pop-
ulations. Non-synonymous SNPs (nsSNPs) comprise a
group of SNPs that, together with SNPs in regulatory
regions, are believed to have the highest impact on pheno-
type [4].
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The genetic basis of behaviour has been explored within a
wide range of genes representing neurotransmitters and
signalling molecules, and the vast majority of work has
been performed on monoamine systems. The serotonin
and dopamine signalling systems are central to different
behavioural phenotypes, both of invertebrates and verte-
brates [5-9]. Marino et al. [10] reported that defects in the
noradrenergic system have been implicated in many
mood, cognitive and neurological disorders that manifest
abnormal social behaviour, and demonstrate that
dopamine β-hydroxylase knock-out (Dbh-/-) mice are defi-
cient in social discrimination and lack isolation-induced
aggression. Monoamine oxidase (MAO) A and B play an
important role in regulating levels of biogenic amines.
Whereas MAOA preferentially oxidises the biogenic
amines serotonin, norepinephrine and epinephrine,
MAOB preferentially oxidises phenylethylamine and ben-
zylamine. Dopamine, tyramine and tryptamine are com-
mon substrates for both forms [11]. MAO A/B double
knock-out mice showed increased brain levels of several
biogenic amines, and chase/escape and anxiety-like
behaviour, suggesting that alterations of monoamine lev-
els are implicated in a unique biochemical and behav-
ioural phenotype [12]. Polymorphism within receptor
genes of dopamine and serotonin are associated with a
variety of human psychiatric disorders [13-16], and
knockout models of 5HTR1B  produce a deviant mice
behaviour [17].
The knowledge of genes associated to behavioural traits is
increasing. Characterisations of these genes and identifi-
cation of closely linked SNPs and microsatellites make it
possible to study the segregation of behaviour-associated
haplotypes and to learn more about the genetic contribu-
tion to canine behaviour. SNPs as abundant polymor-
phisms scattered over the genomes are important tools for
detailed mapping [18]. Beside their value as markers,
some of these variations represent polymorphisms with
functional effects. Descriptions of genetic variation in
expressed sequences and changes in protein sequence may
contribute to reveal the causes of differences in behav-
ioural phenotypes.
The large number of canine breeds exhibits an extreme
between-breed variation in traits like size, colour, confor-
mation and behaviour. For many of these breeds, behav-
ioural characteristics represent an important part of the
breed definition and description. Certain behavioural
phenotypes are associated with specific breeds as a result
of long-term, systematic selection and limited genetic var-
iation. In a behavioural context, dog breeds are evidence
for the considerable impact of genetics on behavioural
traits. They are therefore valuable models for genetic stud-
ies aimed at revealing basic biological knowledge of
genetic regulation of behavioural traits. This can be effi-
ciently performed through crossbreeding and backcrosses
of these isolates with strong between-breed contrasts in
specific behaviours.
Some recent publications characterise polymorphisms in
the canine dopamine and serotonin gene families [19-
23], but the number of reported SNPs in coding sequence
of behaviour-related genes from dogs is still low. A better
knowledge of genetic variation in these genes will be
important for an improved understanding of the genetic
influence on behaviour in both animals and humans. This
study presents novel SNPs in coding sequences of canine
serotonin- and dopamine-related genes.
Results
Sequencing a total number of 24,895 bp coding DNA in
each of eight dogs of different breeds revealed a total of 34
SNPs, 30 of them not earlier reported, distributed in 14 of
the 18 selected genes (Table 1). SNPs were identified in
five genes in the dopamine pathway, in one gene related
to synthesis of norepinephrine and in nine genes in the
serotonin pathway (Table 2).
The 34 SNPs comprised 23 synonymous and 11 non-syn-
onymous, with the predicted changes in amino acids as
described in Table 2 (for flanking nucleotide sequences
see Additional file 1). Of the 11 nsSNPs, three held the
first position, seven held the second position and one
held the third position of the codon. Categorisation of the
SNPs according to nucleotide substitution gave 31(91%)
transitions and 3 (9%) transversions, the transversions all
being nsSNPs. Six of the 11 nsSNPs resulted in a substitu-
tion of amino acid residue with a concomitant shift of
class dependent on R group, and change in structural
parameters (Table 3). Looking at conservation of amino
acids in the location of detected nsSNPs we found that
across five mammalian species (Homo sapiens, Pan troglo-
dytes, Canis familiaris, Mus musculus and Rattus norvegius, at
HomoloGene, [24]) four of the sites were reported invar-
iant and seven reported variable (Table 3). Part of the
alignment of the protein products from these five species,
containing the canine nsSNPs (ClustalW, [25]) are shown
in Figure 1.
The potential functional effects of the 11 identified substi-
tutions caused by the nsSNPs were explored using the
software PolyPhen [4], designed to predict functional
effects of amino acid substitutions (in humans). The pre-
dictions are classified as unknown, benign, possibly dam-
aging and probably damaging. The results showed that
the effect of the amino acid substitution was predicted to
change the function in three of the residues (possibly/
probably damaging) and was classified as benign in seven
of the substitutions. In one of the substitutions the effect
was unknown (Table 3).BMC Genetics 2008, 9:10 http://www.biomedcentral.com/1471-2156/9/10
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Discussion
Being the most frequent variation of DNA, SNPs represent
important causes of transcript variation. The identifica-
tion and closer study of these polymorphisms are impor-
tant for the assignment of the genetic contribution to
different phenotypes. This study describes SNPs in genes
from neurotransmitter systems that are reported to be
related to different behavioural phenotypes.
SNP frequencies show a considerable variation between
species [18,26-28], and Lindblad-Toh et al. [29] presents
in dog a between-breed SNP frequency of ~1/900 bp
based on shotgun sequence data from each of nine diverse
breeds compared to the boxer genome. The SNP fre-
quency detected in our study (1/732, see Table 1), where
a higher number of chromosomes are compared, falls
within this range. We are not aware of prior studies report-
ing SNP frequency of coding sequences from a number of
canine genes.
In our study we observed a ~2.5 times higher number of
SNPs in dopamine-related genes compared to serotonin-
related genes. In the group of dopamine-related genes we
observed 15 SNPs/7,386 bp sequenced (1/492), while 12
SNPs/14,218 bp (1/1184) were observed in the group of
serotonin-related genes (p < 0.05). This may indicate a
greater conservation or a greater similarity in the gene
structure of the serotonin-related genes compared to the
group of dopamine-related genes. The two gene sets rep-
resent genes with similar function related to the respective
neurotransmitters. The G-coupled receptors are, however,
more numerously represented among the serotonin
related genes (Table 1). One gene, HTR3A is a ligand-
gated ion channel and is kept out of the analysis.
Since the completion of the sequence for several genomes,
there has been an increased focus on functional polymor-
phism. Databases containing huge numbers of SNPs are
now available for the research community. Besides outlin-
ing genome architecture with gene location and descrip-
Table 1: List of genes included in the study, with sequence screened and SNP frequency
Gene Gene symbol Gene product category/function* Bp screened SNP/bp
Dopamine related genes
Tyrosine hydroxylase TH Presynaptic form. of DOPA 1488 1/1488
Dopamine transporter SLC6A3 Synaptic clearance of Dopamine 1881 1/470
Dopamine receptor D1 DRD1 G protein-coupled receptor 1341 1/335
Dopamine receptor D2 DRD2 G protein-coupled receptor 1332 1/666
Dopamine receptor D3 DRD3 G protein-coupled receptor 1344 1/336
Norepinephrine related gene
Dopamine beta hydroxylase DBH Presynaptic form. of norepinephrine 1839 1/306
Serotonin related genes
5-hydroxytryptamine receptor 1A HTR1A G protein-coupled receptor 1272 1/1272
5-hydroxytryptamine receptor 1B HTR1B G protein-coupled receptor 1170 1/585
5-hydroxytryptamine receptor 1D HTR1D G protein-coupled receptor 1134 1/283
5-hydroxytryptamine receptor 1E HTR1E G protein-coupled receptor 1098 1/1098
5-hydroxytryptamine receptor 1F HTR1F G protein-coupled receptor 1101 1/1101
5-hydroxytryptamine receptor 2A HTR2A G protein-coupled receptor 1414 0
5-hydroxytryptamine receptor 2B HTR2B G protein-coupled receptor 1305 1/652
5-hydroxytryptamine receptor 2C HTR2C G protein-coupled receptor 1377 1/1377
5-hydroxytryptamine receptor 3A HTR3A Ligand-gated ion channel 1452 1/1452
5-hydroxytryptamine receptor 4 HTR4 G protein-coupled receptor 1167 0
Serotonin transporter SLC6A4 Synaptic clearance of Serotonin 1845 0
Tryptophan hydroxylase 1 TPH1 Presynaptic form. of hydroxytryptophan (5HT) 1335 0
Sum of bp screened 24895
No. of SNPs detected 34
Frequency of SNPs (snp/bp) 1/732
Synonym (n = 23) 1/1082
Non-synonym (n = 11) 1/2263
* As defined at [35]BMC Genetics 2008, 9:10 http://www.biomedcentral.com/1471-2156/9/10
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Table 2: SNPs according to position, function, predicted changes in amino acid and novelty.
Gene CFA* Region Allel Function† Codon 
position
Protein residue‡ Aa 
position
Novelty of SNP§ Reference sequence||
TH 18 EX 13 C/T syn 3 Asp [D] 482 Novel [GenBank: 
NM_001002966.1]
SLC6A3 34 EX 9 A/G syn 3 Gly [G] 418 Novel [GenBank: XM_846543.1]
EX 10 C/T syn 3 Asp [D] 468 Publ. – rs23877306 [GenBank: XM_846543.1]
EX 10 A/G syn 3 Ala [A] 471 Novel [GenBank: XM_846543.1]
EX 11 C/T syn 3 Asp [D] 498 Novel [GenBank: XM_846543.1]
DRD1 4 EX 1 A/G syn 3 Ala [A] 84 Novel [GenBank: XM_546227.2]
EX 1 C/T syn 3 Gly [G] 88 Novel [GenBank: XM_546227.2]
EX 1 C/T syn 3 Val [V] 236 Novel [GenBank: XM_546227.2]
EX 1 C/T ns 2 Thr [T]/Met [M] 354 Novel [GenBank: XM_546227.2]
DRD2 5 EX 2 C/T syn 3 Asn [N] 23 Novel [GenBank: 
NM_001003110.1]
EX 2 C/T syn 3 Ala [A] 77 Novel [GenBank: 
NM_001003110.1]
DRD3 33 EX 4 C/T syn 3 Cys [C] 231 Novel [GenBank: XM_545106.2]
EX 6 A/G ns 2 Gln [Q]/Arg [R] 294 Novel [GenBank: XM_545106.2]
EX 6 C/T ns 1 Leu [L]/Phe [F] 341 Novel [GenBank: XM_545106.2]
EX 7 C/T syn 3 Cys [C] 402 Novel [GenBank: XM_545106.2]
DBH 9 EX 1 A/G syn 3 Thr [T] 17 Novel [GenBank: 
NM_001005263.1]
EX 2 A/G syn 3 Gln [Q] 121 Novel [GenBank: 
NM_001005263.1]
EX 3 C/T syn 3 Tyr [Y] 163 Novel [GenBank: 
NM_001005263.1]
EX 4 A/C ns 3 Lys [K]/Asn [N] 263 Novel [GenBank: 
NM_001005263.1]
EX 4 C/T syn 3 Gly [G] 297 Novel [GenBank: 
NM_001005263.1]
EX 12 A/G syn 3 Gly [G] 622 Novel [GenBank: 
NM_001005263.1]
HTR1A 2 EX1 A/C ns 1 Lys [K]/Gln [Q] 270 Publ. – rs22855024 [GenBank: XM_544358.1]
HTR1B 12 EX 1 A/C ns 1 Ile [I]/Leu [L] 53 Novel [GenBank: 
NM_001006948.1]
EX 1 A/G syn 3 Pro [P] 82 Novel [GenBank: 
NM_001006948.1]
HTR1D 2 EX 1 C/T ns 2 Ala [A]/Val [V] 97 Novel [GenBank: 
NM_001003280.1]
EX 1 C/T syn 3 Tyr [Y] 221 Novel [GenBank: 
NM_001003280.1]
EX 1 A/G ns 2 Glu [E]/Gly [G] 263 Publ. – rs22791523 [GenBank: 
NM_001003280.1]
EX 1 C/T syn 3 His [H] 372 Novel [GenBank: 
NM_001003280.1]
HTR1E 12 EX 1 C/T syn 1 Leu [L] 39 Novel [GenBank: XM_539028.1]
HTR1F 31 EX 1 C/T syn 3 Arg [R] 162 Publ. – rs9250875 [Ensembl: 
ENSCAFT00000012417]
HTR2B 25 EX 1 C/T ns 2 Thr [T]/Ile [I] 88 Novel [GenBank: 
NM_001024633.1]
EX 3 C/T ns 2 Ala [A]/Val [V] 431 Novel [GenBank: 
NM_001024633.1]
HTR2C X EX 6 A/G syn 3 Pro [P] 280 Novel [GenBank: 
NM_001006648.1]
HTR3A 5 EX 2 C/T ns 2 Thr [T]/Met [M] 64 Novel [GenBank: XM_546517.2]
* Chromosome number, Canis familiaris.
† Synonymous SNP (syn) and non-synonymous SNP (ns)
‡ Listed ambiguity is decided by the respective allel in column 4.
§ Novelty of SNPs explored by blasting the dbSNP (Dog_9615) at [36]. Reference no. given for corresponding published SNP.
|| Canine sequence/predicted sequence, for defining SNPs position in protein. Given as GenBank or Ensemble accession number.BMC Genetics 2008, 9:10 http://www.biomedcentral.com/1471-2156/9/10
Page 5 of 8
(page number not for citation purposes)
tion of polymorphisms, one of the major challenges is to
infer the functional implications of these variations. It has
been estimated that ~20% of common human nsSNPs
damage the protein [30]. A large database for identifica-
tion of human nsSNPs with potential impact on disease
(PolyDoms, [31]) uses two sequence homology-based
tools, SIFT [32] and PolyPhen [4], to predict the potential
impact of nsSNP on protein function. Among the struc-
tural parameters analysed in PolyPhen for assessing a pos-
sible damaging effect of amino acid substitutions are
properties in relation to changes of hydrophobicity and
electrostatic charge, as well as protein solubility and com-
patibility of amino acid substitutions in homologous pro-
teins. The changes of R-group classes seen in six of the
substitutions in our study (Table 3) represent a change in
such structural parameters. When inferring about the
effect of the predicted amino acid substitutions it can be
useful to combine data describing biochemical properties
of residues, with knowledge of the conservation across
species. Table 3 shows that four residues are evolutionary
conserved between the five compared species. Of these,
two also experience a change in class of R-group. Presum-
ably one would expect these two substitutions to be the
ones most likely to cause functional changes in the pro-
tein
Conclusion
We have identified a number of coding SNPs in behav-
iour-related genes, several of which change the amino
acids of the proteins. Some of the canine SNPs exist in
codons that are evolutionary conserved between five com-
pared species, and predictions indicate that they may have
a functional effect on the protein. The reported coding
SNP frequency of the studied genes falls within the range
of SNP frequencies reported earlier in the dog and other
mammalian species. Novel SNPs are presented and the
results show a significant genetic variation in expressed
sequences in this group of genes. The results can contrib-
ute to an improved understanding of the genetics of
behaviour.
Methods
Materials
Blood samples were collected from eight dogs of eight dif-
ferent breeds – rottweiler, Labrador retriever, Newfound-
land, golden retriever, English setter, boxer, Norwegian
lundehund and German shepherd. All dogs were healthy
pets visiting the veterinary clinic for routine control.
DNA isolation
DNA was isolated from 10 ml of EDTA-blood by the phe-
nol-chloroform method [33]. DNA was aliquoted and
stored at -20°C.
Identification of genomic sequences
The initial identification of relevant canine sequence was
performed using comparative genomics, facilitated
through the high degree of similarity between human and
canine genomes [28,29]. Published human and canine
sequences from NCBI and ENSEMBLE were aligned and
Table 3: Shift of residues with change of class according to R groups, conservation across species and PolyPhen predictions.
Gene Protein residue* Aa position Change in class according to R 
group†
Residue conservation across 5 
species‡
PolyPhen prediction§
DRD1 Thr [T]/Met [M] 354 No change Invariant Possibly damaging
DRD3 Gln [Q]/Arg [R] 294 Polar, uncharged/positively 
charged
Variable Benign
Leu [L]/Phe [F] 341 Nonpolar, aliphatic/aromatic Invariant Benign
DBH Lys [K]/Asn [N] 263 Positively charged/polar, 
uncharged
Variable Benign
HTR1A Lys [K]/Gln [Q] 270 Positively charged/polar, 
uncharged
Variable Benign
HTR1B Ile [I]/Leu [L] 53 No change Variable Benign
HTR1D Ala [A]/Val [V] 97 No change Invariant Benign
Glu [E]/Gly [G] 263 Negatively charged/Nonpolar, 
aliphatic
Variable Benign
HTR2B Thr [T]/Ile [I] 88 Polar, uncharged/nonpolar, 
aliphatic
Invariant Probably damaging
Ala [A]/Val [V] 431 No change Variable Predicted to be unknown
HTR3A Thr [T]/Met [M] 64 No change Variable Possibly damaging
* Changes according to Table 2, shift in residues as result of different alleles of SNPs.
† Changes according to shift of residues in column 2, respectively. Classes according to R groups as described by [37].
‡ Residue variation across five mammalian species.
§ Prediction of a possible damaging effect of the amino acid substitutions caused by the nsSNPs, performed with PolyPhen [4].BMC Genetics 2008, 9:10 http://www.biomedcentral.com/1471-2156/9/10
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Alignment showing amino acid variation across five species in location of nsSNPs Figure 1
Alignment showing amino acid variation across five species in location of nsSNPs. The alignment show selected 
parts of the protein sequence containing the 11 detected nsSNPs in the dog, marked as bold and underlined residues. Only 
four species are aligned for the DRD1 gene since there was no homologous gene available for the Chimpanzee (HomoloGene, 
[24]).
DRD1 Human  LCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSE 399
Dog LCPTTNNAIETVSINNNGAVVFSSHHEPRGSISKDCNLVYLIPHAVGSSE 399
Mouse LCPTTNNAIETVSINNNGAVMFSSHHEPRGSISKDCNLVYLIPHAVGSSE 399
Rat LCPTTNNAIETVSINNNGAVVFSSHHEPRGSISKDCNLVYLIPHAVGSSE 399
***:***************.:*************:***************
DRD3 Human  ---------------------------------------LSPDPAHLELK 253
Chimp ---------------------------------------LSPDPAHLELK 253
Dog RQFSIRDRFPSDATGQMEHSEDKRYPQKCQDPLLSQLQPLSPSQAHMELK 300
Mouse RQFSIRARFLSDATGQMEHIEDKPYPQKCQDPLLSHLQPLSPGQTHGELK 300
Rat RQFSIRARFLSDATGQMEHIEDKQYPQKCQDPLLSHLQPPSPGQTHGGLK 300
**. :*  **
DRD3 Human  RYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSN 303
Chimp RYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSN 303
Dog RYYSICQDTALGQPGFQEAGGELKREGRTRNSLSPTMAPKLSLEVRKLSN 350
Mouse RYYSICQDTALRHPNFEGGGG-MSQVERTRNSLSPTMAPKLSLEVRKLSN 349
Rat RYYSICQDTALRHPSLEGGAG-MSPVERTRNSLSPTMAPKLSLEVRKLSN 349
***********  *.::  .* :.   :********:*************
DBH Human  IKYEPIVTKGNEALVHHMEVFQCAPEMDSVPHFSGPCDSKMKPDRLNYCR 282
Chimp IKYEPIVTKGNEALVHHMEVFQCAPELDSVPHFSGPCDSKMKPDRLNYCR 296
Mouse IMYEAIVTEGNEALVHHMEVFQCAAESEDFPQFNGPCDSKMKPDRLNYCR 300
Rat IMYEAIVTEGNEALVHHMEVFQCTNESEAFPMFNGPCDSKMKPDRLNYCR 299
Dog VMYEPIITKGNEALVHHIEIFQCTNQFQNITSFSGSCDSKEKPQELKVCR 288
: **.*:*:********:*:***: : : .. *.*.**** **:.*: **
HTR1A Human KKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN 300
Chimp KKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN 300
Dog RKSVNGEPGGREWRQGPGSQAGGPLCTNGAVRRGDDGAALEVIEVHRVGS 300
Mouse KKSLNGQPGSGDCRRSAENRAVGTPCANGAVRQGEDDATLEVIEVHRVGN 300
Rat KKSLNGQPGSGDWRRCAENRAVGTPCTNGAVRQGDDEATLEVIEVHRVGN 300
:**:**:.*. : *    .:* *. *:*****:*:* *:**********.
HTR1B Human LLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSI 100
Chimp LLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSI 100
Dog LLVILLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSI 99
Mouse LLVALLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSI 96
Rat LLVALLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSI 96
*** **********************************************
HTR1D Human ATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTI 100
Chimp ATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTI 100
Mouse ATVLSNAFVLTTILLTKKLHTPANYLIGSLATTDLLVSILVMPISIAYTT 97
Rat ATVLSNAFVLTTILLTKKLHTPANYLIGSLATTDLLVSILVMPISIAYTT 97
Dog ATALSNAFVLTTIFLTRKLHTPANYLIGSLAMTDLLVSILVMPISIAYTT 100
**.**********:**:************** ***************** 
HTR1D Human SSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKAT 300
Chimp SSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKAT 300
Mouse SSLCSLNPSLHESHTHTVGSPLFFNQVKIKLADSILERKRISAARERKAT 297
Rat SSLCSLNPSLHESHTHTVGSPLFFNQVKIKLADSILERKRISAARERKAT 297
Dog SSLCSLSPSLQEERSHAAGPPLFFNHVQVKLAEGVLERKRISAARERKAT 300
******..**:* ::*:.*.*****:*::***:. ***************
HTR2B Human GNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVAD 100
Chimp GNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVAD 100
Dog GKKPQWAALLILTVIIPTIGGNILVILAISLEKKLQYATNYFLMSLAVAD 99
Mouse GHTVHWAALLILAVIIPTIGGNILVILAVALEKRLQYATNYFLMSLAIAD 99
Rat GNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVAD 99
*:. :******: ********* *****::***:*************:**
HTR2B Human ATKSVKTLRKRSSKIYFRNPMAENSKFFKKHGIRNGINPAMYQSPMRLRS 450
Chimp ATKSVKTLRKRSSKIYFRNPMAENSKFFKKHGIRNGINPAMYQSPMRLRS 450
Dog AMKSVKTVRKCSSNNYFRN--GRELKVFHET-----WNVKWY-------- 434
Mouse ATKSVKALRKFSSTLCFGNSMVENSKFFTKHGIRNGINPAMYQSPMRLRC 449
Rat ATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRS 449
* ****.:** **.  * *   .: *.* :       *   *        
HTR3A Human RKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFL 95
Chimp RKGVRPVRDWRKPTTISIDVIVYAILNVDEKNQVLTTYIWYRQHWTDEFL 95
Dog QKGVRPVRDWRKPTTVSIDVIVYAILSVDEKNQVLTTYIWYRQYWTDEFL 100
Mouse KKGVRPVRDWRKPTTVSIDVIMYAILNVDEKNQVLTTYIWYRQYWTDEFL 99
Rat KKGVRPVRDWRKPTLVSIDVIMYAILNVDEKNQVLTTYIWYRQFWTDEFL 94
:************* :*****:****.****************.******BMC Genetics 2008, 9:10 http://www.biomedcentral.com/1471-2156/9/10
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primers were designed to amplify exonic sequence
(primer 3, [34]).
The selected exonic sequences originated from a total of
18 genes, consisting of nine serotonin G protein-coupled
receptors and one ligand-gated ion channel, three
dopamine G protein-coupled receptors and additionally
exons from four genes related to serotonin and dopamine
formation and synaptic clearance. The study also included
one enzymatic gene related to synthesis of norepine-
phrine (Table 1).
PCR amplification and SNP detection
Primers flanking each of the exon sequences of 12 serot-
onin-, five dopamine- and one norepinephrine-related
genes (Table 1) were run in PCR with ~25 ng of canine
genomic DNA as template, 1.5 μl 10× PCR buffer contain-
ing 15 mM MgCl2 (Qiagen), 0.6 μl dNTP (2.5 mM), 0.5 μl
PCR primer, forward and reverse (5 pmol/μl), 0.05 μl Taq
DNA Polymerase (5 U/μl, Qiagen) and water to a total
volume of 15 μl. Initial denaturation at 95°C (2 1/2
min.), followed by 34 cycles of 95°C (30 sec.), 58°C (40
sec.), 72°C (50 sec.) and finally at 72°C (5 min.). Primers
not providing specific PCR products by these conditions
were run at 95°C (2 1/2 min.), followed by 34 cycles of
95°C (30 sec.), 60°C (40 sec.), 72°C (50 sec.) and finally
at 72°C (5 min.).
The obtained PCR products were sequenced in both for-
ward and reverse directions with the same PCR primers,
by the MegaBACE™ 1000 DNA Analysis Systems (Amer-
sham Biosciences) using the DYEnamic™ ET Dye Termina-
tor Kit (Amersham Biosciences). Reaction conditions were
as follows: 4 μl ET reagent premix, 4.5 μl H2O, 1 μl PCR-
product and 0.5 μl primer (5 μM) with the following step
repeated 28 times: 95°C (15 sec.), 58°C (10 sec.), 60°C
(1 min.). The post-reaction cleanup was performed as rec-
ommended by the protocol with ethanol and 7.5 M
ammonium acetate. SNPs were identified by aligning and
comparing the sequence data with Sequencher 4.1.4
(Gene Codes Co.)
SNP description and possible amino acid change
Reference sequences were displayed from available data-
bases and open reading frames (ORFs) defined. Further
alignment and translation with Sequencher 4.1.4 (Gene
Codes Co.) defined the codons and amino acid changes
(Table 2). Alignment of protein sequences with nsSNPs
(reference sequences in Table 2) for detection of conserva-
tion across species was performed with ClustalW [25].
Prediction of a possible damaging effect of the amino acid
substitutions caused by the nsSNPs was performed with
PolyPhen [4].
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